ZBH Stock Analysis: Buy, Sell, or Hold?
ZBH - Zimmer Biomet Holdings, Inc.
$87.47
3.30 (3.92%)
▲
5d:
-3.84%
30d:
+4.44%
90d:
-3.91%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ZBH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ZBH shows positive signals but monitor for confirmation. Market pricing in 1.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ZBH shows positive signals but monitor for confirmation. Market pricing in 1.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$117.01
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$72.66
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZBH is currently trading at $87.47, which is considered fair relative to its 30-day fair value range of $84.24 to $89.80. The stock's valuation (Forward PE: 9.7) is in line with its historical norms (10.2). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This pessimistic expectation contrasts with the company's recent 34.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ZBH is in a downtrend. Immediate support is located at $83.72, while resistance sits at $93.34. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $98.70 (+12.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZBH is in a downtrend. Immediate support is located at $83.72, while resistance sits at $93.34. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $98.70 (+12.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$84.24 -
$89.80
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading below Wall St target ($98.70)
Trading Range Analysis
30-Day Trading Range
$84.24 -
$89.80
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$83.72
Resistance Level
$93.34
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.73
Wall Street Target
$98.70
(+12.8%)
Revenue Growth (YoY)
9.3%
Earnings Growth (YoY)
34.1%
Profit Margin
9.0%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
9.7 vs 10.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$86.16
(-2%)
2-Year Target
$84.87
(-3%)
3-Year Target
$83.59
(-4%)
3-Yr Target (if PE normalizes)
(PE: 10→10)
$87.63
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 6.0%)
$233.43
(+167%)
Base:
(SPY PE: 9.7, Growth: 6.0%)
$104.28
(+19%)
Bear:
(PE: 8.3, Growth: 6.0%)
$88.64
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 21.81 | Current EPS (TTM): $3.86
Bull Case
$185.17
(+112%)
Analyst growth 100.0%, PE expands to 24.0
Base Case
$168.34
(+93%)
Market implied 100.0%, PE stable at 21.8
Bear Case
$57.24
(-35%)
Severe decline -20.0%, PE contracts to 18.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.7 to 10.2
Stabilization Target:
$91.69
(+4.8%)
PE Expansion Potential:
+4.8%
Share & Embed Analysis
Last updated: July 03, 2026 7:13 PM ET
Data refreshes hourly during market hours. Next update: 8:13 PM
Data refreshes hourly during market hours. Next update: 8:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBH showing a specific setup today?
Insider Activity (6 Months)
5
Buys
4
Sells
+
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-23
Lori Winkler
SELL
2650 shares
2026-03-12
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
Advanced ZBH Option Strategies
Professional options setups generated by AI based on today's ZBH price and gamma walls.
